Invesco Ltd. Paratek Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.37 - $2.54 $7,536 - $13,972	5,501 Added 52.14%	16,051 $40,000
Q4 2022 Feb 13, 2023	BUY	$1.67 - $2.51 $17,618 - $26,480	10,550 New	10,550 $19,000
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $31,505 - $56,271	-18,211 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $2,249 - $3,649	765 Added 4.38%	18,211 $54,000
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $4,224 - $5,501	-1,038 Reduced 5.62%	17,446 $79,000
Q3 2021 Nov 15, 2021	BUY	$4.7 - $7.24 $18,565 - $28,598	3,950 Added 27.18%	18,484 $90,000
Q2 2021 Aug 17, 2021	BUY	$6.81 - $10.93 $98,976 - $158,856	14,534 New	14,534 $99,000
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $652,585 - $1.02 Million	-142,486 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.19 - $6.69 $597,016 - $953,231	142,486 New	142,486 $771,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.